Abstract
Human papillomavirus vaccines have potential to reduce cervical cancer incidence and mortality; however, cultural and economic barriers may hinder success in developing countries. We assessed impact of a single vaccine campaign in Mali with use of mathematical modeling. Our model shows that decreases in the prevalence of Human papillomavirus infection are proportional to achieved vaccination coverage.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 641-645 |
| Number of pages | 5 |
| Journal | Clinical Infectious Diseases |
| Volume | 52 |
| Issue number | 5 |
| DOIs | |
| State | Published - Mar 1 2011 |
Fingerprint
ASJC Scopus subject areas
- Infectious Diseases
- Microbiology (medical)
Cite this
Estimating the impact of Human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali. / Tracy, Laree; Gaff, Holly D.; Burgess, Colleen; Sow, Samba; Gravitt, Patti E.; Tracy, J. Kathleen.
In: Clinical Infectious Diseases, Vol. 52, No. 5, 01.03.2011, p. 641-645.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Estimating the impact of Human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali
AU - Tracy, Laree
AU - Gaff, Holly D.
AU - Burgess, Colleen
AU - Sow, Samba
AU - Gravitt, Patti E.
AU - Tracy, J. Kathleen
PY - 2011/3/1
Y1 - 2011/3/1
N2 - Human papillomavirus vaccines have potential to reduce cervical cancer incidence and mortality; however, cultural and economic barriers may hinder success in developing countries. We assessed impact of a single vaccine campaign in Mali with use of mathematical modeling. Our model shows that decreases in the prevalence of Human papillomavirus infection are proportional to achieved vaccination coverage.
AB - Human papillomavirus vaccines have potential to reduce cervical cancer incidence and mortality; however, cultural and economic barriers may hinder success in developing countries. We assessed impact of a single vaccine campaign in Mali with use of mathematical modeling. Our model shows that decreases in the prevalence of Human papillomavirus infection are proportional to achieved vaccination coverage.
UR - http://www.scopus.com/inward/record.url?scp=79951832979&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951832979&partnerID=8YFLogxK
U2 - 10.1093/cid/ciq190
DO - 10.1093/cid/ciq190
M3 - Article
VL - 52
SP - 641
EP - 645
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - 5
ER -